Figure 1
Figure 1. Time course of T cell expansion from CLL peripheral blood using blinatumomab and rhIL-2, shown as percentage (A) and absolute numbers (B) of CD3+ and CD19+ cells. N=13

Time course of T cell expansion from CLL peripheral blood using blinatumomab and rhIL-2, shown as percentage (A) and absolute numbers (B) of CD3+ and CD19+ cells. N=13

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal